Archynetys Live news trend intelligence
↓ Cooling Business 🔮 Archynetys predicts: fades by tomorrow

KKR to Buy Integer Holdings for $4.3 Billion in Cash

KKR is buying Integer Holdings for $4.3 billion in cash, according to the Wall Street Journal.

8sources
8articles
6velocity
-60%since first seen
7h agofirst detected

Evidence dossier

Intelligence passport

60/100 Strong
8distinct sources shown
8velocity measurements
1language editions checked
Unsupported statements were removed before publicationbrief evidence status

Measured timeline

  1. Detected The first matching coverage entered the Archynetys cluster.
  2. Evidence threshold reached The story had enough independent coverage for an explanatory brief.
  3. Latest coverage observed Most recent article currently attached to this story cluster.
  4. Peak measured velocity The recorded velocity reached 28.

Source diversity sample: MassDevice · The Business Journals · MedTech Dive · PR Newswire · Financial Times · Bloomberg.com · Reuters · WSJ.

How this dossier is built: methodology · AI policy · corrections.

How fast it spread

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Where it stands

$4.3 billion in cash is the price KKR will pay to take medical-equipment maker Integer Holdings private. The deal is part of a broader trend of private equity firms acquiring publicly traded companies.

The Financial Times and Reuters report a higher price, $5.7 billion. The discrepancy is not yet explained.

The acquisition is subject to regulatory approval and shareholder vote. The terms of the deal, including the exact purchase price and the timeline for completion, have not been fully disclosed.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (86% supported) Updated 7h ago.

Sources (8)

Answered

What is the purchase price for Integer Holdings?

The Wall Street Journal reports $4.3 billion in cash. The Financial Times and Reuters report $5.7 billion.

What is the status of the deal?

The acquisition is subject to regulatory approval and shareholder vote.

What is the timeline for the completion of the deal?

The timeline for completion has not been disclosed.

Topics

KKR Integer Holdings private equity medical devices acquisition

Related trends

Open prediction lab

Can you beat the machine?

Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.

Make a prediction →